Table 2.
C31G (N=932) | Conceptrol (N=633) | |||||||
---|---|---|---|---|---|---|---|---|
Population | # pregnancies |
Pregnancy probability (%) |
95% CI | # pregnancies |
Pregnancy probability (%) |
95% CI | Diff | 95% CI |
6-month | ||||||||
ITT | 88 | 11.4 | 8.8 – 14.1 | 60 | 11.6 | 8.4 – 14.9 | −0.2 | −4.4 – 3.9 |
MITT | 85 | 12.0 | 9.3 – 14.7 | 57 | 12.0 | 8.7 – 15.3 | 0.0 | −4.3– 4.3 |
CC | 17 | 4.8 | 1.6 – 7.9 | 12 | 4.5 | 0.7 – 8.3 | 0.3 | −4.7 – 5.2 |
12-month | ||||||||
MITT | 91 | 13.8 | 7.6 – 20 | 68 | 19.8 | 10.9 – 28.7 | −6.0 | −16.9 – 4.9 |
CC | 17 | 5.5 | 0.0 – 16.1 | 13 | 6.6 | 0.0 – 20.1 | −1.0 | −18.2 – 16.2 |
ITT = Intent-to-treat; MITT= Modified intent-to-treat; CC= Correct and consistent use (efficacy-evaluable)